Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve 1. Un-audited Financial results for the quarter ended June 30, 2025. 2. Limited Review Report for the quarter ended June 30, 2025. 3. Any other business with the permission of the Chair.